Cabaletta Bio is trading at $1.69, down 5.87%, with no clear company-specific catalyst identified for the October 13 drop.

  • Shares were down from the October 12 close of $1.79, extending a seven-session decline from $2.08 on October 5.
  • The latest located release was October 5 inducement grants; October 13 coverage discussed the existing decline and insider purchases, not a new trigger.
  • Broader indexes were nearly flat, offering no clear market-wide explanation.